Clinical trials
Phase 2 Triple Negative Breast Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 6 |
| Completed | 6 |
| Terminated | 4 |
| Recruiting | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| National Cancer Institute (NCI) | 3 |
| AHS Cancer Control Alberta | 2 |
| AstraZeneca | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Celldex Therapeutics | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Nathalie Levasseur | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 21 |
| Breast Neoplasms | 10 |
| Ovarian Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Esophageal Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Breast Neoplasms, Male | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.